Abstract
MDM2 is the key negative regulator of p53 and an important validated target for anticancer drug discovery. Using the comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) approaches, we performed LibDock based 3D-QSAR study on 42 isoindolinone derived MDM2 inhibitors for the first time. We found in CoMFA model including steric and electrostatic fields for the training set, the cross-validated q2 value was 0.66 and the non-cross-validated r2 value was 0.98, while, the cross-validated q2 value was 0.58 and the noncross- validated r2 value was 0.96 in CoMSIA Model. These results indicated that the CoMFA and CoMSIA analyses are very useful tools in the development of more potent p53-MDM2 binding inhibitors.
Keywords: p53-MDM2, Isoindolinone, 3D-QSAR, LibDock.
Letters in Drug Design & Discovery
Title:The Docking Based 3D-QSAR Studies on Isoindolinone Derived Inhibitors of p53-MDM2 Binding
Volume: 11 Issue: 1
Author(s): Huazhou Ying, Chunlei Wu and Chunqi Hu
Affiliation:
Keywords: p53-MDM2, Isoindolinone, 3D-QSAR, LibDock.
Abstract: MDM2 is the key negative regulator of p53 and an important validated target for anticancer drug discovery. Using the comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) approaches, we performed LibDock based 3D-QSAR study on 42 isoindolinone derived MDM2 inhibitors for the first time. We found in CoMFA model including steric and electrostatic fields for the training set, the cross-validated q2 value was 0.66 and the non-cross-validated r2 value was 0.98, while, the cross-validated q2 value was 0.58 and the noncross- validated r2 value was 0.96 in CoMSIA Model. These results indicated that the CoMFA and CoMSIA analyses are very useful tools in the development of more potent p53-MDM2 binding inhibitors.
Export Options
About this article
Cite this article as:
Ying Huazhou, Wu Chunlei and Hu Chunqi, The Docking Based 3D-QSAR Studies on Isoindolinone Derived Inhibitors of p53-MDM2 Binding, Letters in Drug Design & Discovery 2014; 11 (1) . https://dx.doi.org/10.2174/15701808113109990053
DOI https://dx.doi.org/10.2174/15701808113109990053 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Virus-Host Interactions: New Insights and Advances in Drug Development Against Viral Pathogens
Current Drug Metabolism Roles of Natural Compounds from Medicinal Plants in Cancer Treatment: Structure and Mode of Action at Molecular Level
Medicinal Chemistry Prospective Plant Based Anticancer Lead Molecules
Current Topics in Medicinal Chemistry Bacteriophages and Phage-Derived Proteins – Application Approaches
Current Medicinal Chemistry High Throughput Screening Operations at the University of Kansas
Combinatorial Chemistry & High Throughput Screening Preface
Mini-Reviews in Medicinal Chemistry Synthesis and Biological Evaluation of Novel 4-indolyl-5-phenyl(indolyl)- 1,2-dihydropyrazol-3-ones as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors
Letters in Drug Design & Discovery Two-Dimensional QSAR Studies on Arylpiperazines as High-Affinity 5-HT1A Receptor Ligands
Medicinal Chemistry <i>In vitro</i> Inhibition Profiles and Molecular Docking Analysis of Benzohydrazide Derivatives on Red Blood Cell Carbonic Anhydrases Isozymes
Current Computer-Aided Drug Design Synthetic Src-Kinase Domain Inhibitors and Their Structural Requirements
Anti-Cancer Agents in Medicinal Chemistry Mass Spectrometric Analysis of F2-Isoprostanes: Markers and Mediators in Human Disease
Current Pharmaceutical Analysis Recent Progress of Bioactivities, Mechanisms of Action, Total Synthesis, Structural Modifications and Structure-activity Relationships of Indole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Medicinal Chemistry and Biological Properties of Non-Imidazole Histamine H3 Antagonists
Mini-Reviews in Medicinal Chemistry A Bioinorganic Perspective on Matrix Metalloproteinase Inhibition
Current Topics in Medicinal Chemistry Anti-Helicobacter pylori Agents. An Update
Mini-Reviews in Medicinal Chemistry Clinical Value of COVID-19 Chest Radiography and High-Resolution CT Examination
Current Medical Imaging Immunity Modulators, Repurposed Drugs and Candidate Vaccines for COVID-19: A Review
Coronaviruses Exploring 3D-QSAR for Ketolide Derivatives as Antibacterial Agents Using CoMFA and CoMSIA
Letters in Drug Design & Discovery A Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab) in the Therapy of Moderate-to-Severe Allergic Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Synthesis and Antimalarial Activity of Novel Side Chain Modified Antimalarial Agents Derived from 4-Aminoquinoline
Medicinal Chemistry